相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort
Daniele Pastori et al.
MAYO CLINIC PROCEEDINGS (2019)
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation
Daniele Pastori et al.
AMERICAN HEART JOURNAL (2018)
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation
Daniele Pastori et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study
Daniela Poli et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control
Anders Nissen Bonde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
The ABC pathway: an integrated approach to improve AF management
Gregory Y. H. Lip
NATURE REVIEWS CARDIOLOGY (2017)
Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial)
Gregory Y. H. Lip et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Rick A. Nishimura et al.
CIRCULATION (2017)
Quality of Anticoagulation With Vitamin K Antagonists
Vicente Bertomeu-Gonzalez et al.
CLINICAL CARDIOLOGY (2015)
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation
Daniele Pastori et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study
Ashkan Labaf et al.
THROMBOSIS RESEARCH (2014)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: A prospective multicenter cohort study
Francesco Dentali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV
Harvey D. White et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Mechanical versus bioprosthetic valve replacement in middle-aged patients
Alexander Kulik et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
分享论文
